Beta Bionics (BBNX) Total Non-Current Liabilities (2023 - 2026)

Beta Bionics has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $31.6 million for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $31.6 million, up 32.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.6 million (up 32.43% YoY), and the FY2025 annual result was $39.6 million, up 37.77% from the prior year.
• Total Non-Current Liabilities came in at $31.6 million for Q1 2026 at Beta Bionics, down from $39.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $39.6 million in Q4 2025 to a low of $23.9 million in Q1 2025.
• The 4-year median for Total Non-Current Liabilities is $29.1 million (2023), against an average of $30.6 million.
• Across the five-year window, Total Non-Current Liabilities retreated 1.3% in 2024 and surged 37.77% in 2025, its largest moves.
• Beta Bionics' Total Non-Current Liabilities stood at $29.1 million in 2023, then declined by 1.3% to $28.7 million in 2024, then soared by 37.77% to $39.6 million in 2025, then slipped by 20.14% to $31.6 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $31.6 million (Q1 2026), $39.6 million (Q4 2025), and $34.1 million (Q3 2025), per Business Quant data.